A detailed history of Geode Capital Management, LLC transactions in Biodesix Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 533,852 shares of BDSX stock, worth $982,287. This represents 0.0% of its overall portfolio holdings.

Number of Shares
533,852
Previous 385,145 38.61%
Holding current value
$982,287
Previous $550,000 48.36%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$1.21 - $1.71 $179,935 - $254,288
148,707 Added 38.61%
533,852 $816,000
Q1 2024

May 13, 2024

BUY
$1.35 - $2.12 $37,836 - $59,417
28,027 Added 7.85%
385,145 $550,000
Q4 2023

Feb 13, 2024

BUY
$1.2 - $2.13 $94,479 - $167,701
78,733 Added 28.28%
357,118 $657,000
Q3 2023

Nov 13, 2023

SELL
$1.04 - $1.74 $94,813 - $158,630
-91,167 Reduced 24.67%
278,385 $459,000
Q2 2023

Aug 11, 2023

BUY
$1.12 - $1.88 $150,735 - $253,019
134,585 Added 57.28%
369,552 $454,000
Q1 2023

May 15, 2023

BUY
$1.52 - $2.5 $165,444 - $272,112
108,845 Added 86.3%
234,967 $437,000
Q4 2022

Feb 13, 2023

BUY
$0.98 - $2.3 $2,010 - $4,719
2,052 Added 1.65%
126,122 $290,000
Q3 2022

Nov 14, 2022

BUY
$1.24 - $2.89 $33,829 - $78,844
27,282 Added 28.19%
124,070 $157,000
Q2 2022

Aug 12, 2022

SELL
$1.32 - $2.12 $109,218 - $175,410
-82,741 Reduced 46.09%
96,788 $158,000
Q1 2022

May 13, 2022

BUY
$1.69 - $5.81 $31,415 - $108,002
18,589 Added 11.55%
179,529 $303,000
Q4 2021

Feb 11, 2022

BUY
$4.09 - $8.67 $40,560 - $85,980
9,917 Added 6.57%
160,940 $851,000
Q3 2021

Nov 12, 2021

BUY
$6.6 - $12.78 $33,422 - $64,717
5,064 Added 3.47%
151,023 $1.24 Million
Q2 2021

Aug 13, 2021

BUY
$12.14 - $20.35 $860,774 - $1.44 Million
70,904 Added 94.47%
145,959 $1.93 Million
Q1 2021

May 12, 2021

BUY
$16.87 - $31.21 $506,386 - $936,830
30,017 Added 66.65%
75,055 $1.52 Million
Q4 2020

Feb 12, 2021

BUY
$10.89 - $20.16 $490,463 - $907,966
45,038 New
45,038 $907,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $73.6M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.